Russell Katz
Gene Therapy Laboratory(FR)
Publications by Year
Research Areas
Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Economics and Policy, Dementia and Cognitive Impairment Research, Statistical Methods in Clinical Trials, Pharmaceutical studies and practices
Most-Cited Works
- → Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes(2004)1,210 cited
- → Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders(2014)987 cited
- → Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives(2010)628 cited
- → The role of radiotracer imaging in Parkinson disease(2005)372 cited
- → Biomarkers and surrogate markers: An FDA perspective(2004)341 cited
- → Regulatory Innovation and Drug Development for Early-Stage Alzheimer's Disease(2013)196 cited
- → FDA: Evidentiary standards for drug development and approval(2004)94 cited
- → Building a roadmap for developing combination therapies for Alzheimer’s disease(2015)57 cited
- → ENDPOINTS FOR PRE-DEMENTIA AD TRIALS: A REPORT FROM THE EU/US/CTAD TASK FORCE(2015)45 cited
- → Challenges, solutions, and recommendations for Alzheimer's disease combination therapy(2016)45 cited